Clozapine in Treatment-Resistant Bipolar Disorder With Suicidality. Three Case Reports

scientific article published on 19 July 2019

Clozapine in Treatment-Resistant Bipolar Disorder With Suicidality. Three Case Reports is …
instance of (P31):
case reportQ2782326
scholarly articleQ13442814

External links are
P356DOI10.3389/FPSYT.2019.00520
P932PMC publication ID6659350
P698PubMed publication ID31379632

P50authorWiesław Jerzy CubałaQ57009712
Mariusz WigluszQ84416902
Alina WilkowskaQ85907507
P2860cites workDo Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating OverviewQ28077687
Suicidal risk during treatment with clozapine: a meta-analysisQ33984401
Existing and novel biological therapeutics in suicide preventionQ34085866
Intracellular modulation of NMDA receptor function by antipsychotic drugsQ34372226
Real-world effectiveness of clozapine in patients with bipolar disorder: results from a 2-year mirror-image studyQ34644698
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorderQ34649187
Clozapine for Treatment-Refractory Schizophrenia, Schizoaffective Disorder, and Psychotic Bipolar DisorderQ60633571
Clozapine for treatment-refractory maniaQ71085936
Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-upQ72152369
Clozapine associated with decreased suicidality in bipolar disorder: a case reportQ73625587
Suicide in bipolar disorder: Risks and management.Q36525750
Suicide risk in depression and bipolar disorder: Do impulsiveness-aggressiveness and pharmacotherapy predict suicidal intent?Q36836763
Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for PsychopharmacologyQ37426143
International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder.Q38261404
Clozapine for treatment-resistant bipolar disorder: a systematic review.Q38262870
Clozapine in severe mood disordersQ40476928
The effects of clozapine versus haloperidol on measures of impulsive aggression and suicidality in chronic schizophrenia patients: an open, nonrandomized, 6-month study.Q42606780
Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of maniaQ42608014
Low doses of clozapine may stabilize treatment-resistant bipolar patientsQ42640390
Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).Q44268852
Early age at onset as a risk factor for poor outcome of bipolar disorderQ44295348
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.Q45484599
Psychiatrists' attitude towards and knowledge of clozapine treatmentQ46150844
Exploratory investigation of biomarker candidates for suicide in schizophrenia and bipolar disorderQ47788587
Clozapine markedly elevates pregnenolone in rat hippocampus, cerebral cortex, and serum: candidate mechanism for superior efficacy?Q48424732
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P921main subjectbipolar disorderQ131755
P304page(s)520
P577publication date2019-07-19
P1433published inFrontiers in PsychiatryQ27723495
P1476titleClozapine in Treatment-Resistant Bipolar Disorder With Suicidality. Three Case Reports
P478volume10

Search more.